KYNB
Kyntra Bio Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.97
-0.05 ▼ -0.71%
🌙 3월 13일 7:03 PM ET (한국 3/14 08:03)
$6.97
+0.00 +0.00%
| Index | - | P/E | 0.17 | EPS (ttm) | 40.44 | Insider Own | 7.27% | Shs Outstand | 0.00B | Perf Week | 1.9% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | -159.5% | Insider Trans | 1.27% | Shs Float | 0.00B | Perf Month | -10.64% |
| Enterprise Value | -0.03B | PEG | - | EPS next Q | -3.88 | Inst Own | 28.48% | Short Float | 2.98% | Perf Quarter | -20.98% |
| Income | 0.16B | P/S | 3.4 | EPS this Y | 61.62% | Inst Trans | -0.38% | Short Ratio | 2.99 | Perf Half Y | -43.93% |
| Sales | 0.01B | P/B | - | EPS next 5Y | 3.89% | ROA | -26.04% | Short Interest | 0.11M | Perf YTD | -20.62% |
| Book/sh | -4.21 | P/C | 0.24 | EPS past 3/5Y | 46.7% 11.75% | ROE | - | 52W High | -44.68% ($12.60) | Perf Year | -34.72% |
| Cash/sh | 29.16 | P/FCF | - | Sales past 3/5Y | -49.88% -35.07% | ROIC | 6692.22% | 52W Low | 43.71% ($4.85) | Perf 3Y | -98.61% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 231.59% | Gross Margin | 153.91% | Volatility(W/M) | 5.84% 6.46% | Perf 5Y | -99.21% |
| Dividend TTM | - | EV/Sales | -4.12 | Sales Y/Y TTM | -95.39% | Oper. Margin | -458.57% | ATR (14) | 0.47 | Perf 10Y | -98.5% |
| Dividend Ex-Date | - | Quick Ratio | 3.6 | EPS Q/Q | 964.07% | Profit Margin | 1970.01% | RSI (14) | 41.22 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.71 | Sales Q/Q | -97.68% | SMA20 | -4.09% ($7.27) | Beta | 0.91 | Target Price | $43 |
| Payout | - | Debt/Eq | - | Earnings | 3000000 | SMA50 | -13.59% ($8.07) | Rel Volume | 0.53 | Prev Close | $7.02 |
| Employees | 225 | LT Debt/Eq | - | EPS/Sales Surpr. | 1338.08% -55.8% | SMA200 | -21.5% ($8.88) | Avg Volume(3M) | 0.04M | Price | $6.97 |
| IPO | 2014/11/14 | Option/Short | No/Yes | Trades | 222 | Volume | 19,967 | Change | -0.71% |
뉴스 로딩 중...